The decision was based on information that the merger “may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom,” the regulator said March 31.
Bordeaux UK Holdings II — a unit of UnitedHealth’s Optum business — agreed to acquire the U.K.-based EMIS Group in January 2022 in a $1.51 billion deal.
The Competition and Markets Authority began investigating the proposed merger in January, inviting interested parties to submit comments on whether the deal will harm competition.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
